Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
BMJ Open
|
April 1, 2019
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Miklos Rohla, Thomas W Weiss, Ladislav Pecen, et al.
Archives of Cardiovascular Diseases
|
September 25, 2017
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy
Raffaele De Caterina, Bernd Brüggenjürgen, Harald Darius, et al.
Circulation Reports
|
March 11, 2024
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia - One-Year Data From the Global ETNA-AF Program
Jong-Il Choi, Songsak Kiatchoosakun, Panyapat Jiampo, et al.
Anticancer Research
|
October 4, 2011
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study
Petr Pazdiora, Sarka Svobodova, Radka Fuchsova, et al.
JACC. Advances
|
June 28, 2024
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry
Marianne Gwechenberger, Gonzalo Barón-Esquivias, Tim A C de Vries, et al.
International Journal of Cardiology
|
May 1, 2018
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy
Jolanta M Siller-Matula, Ladislav Pecen, Giuseppe Patti, et al.
Journal for Immunotherapy of Cancer
|
December 12, 2018
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
Iva Truxova, Lenka Kasikova, Michal Hensler, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care
Paulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2019
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova, Jana Rakova, Michal Hensler, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
Michal Hensler, Lenka Kasikova, Karel Fiser, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
BMJ Open
|
April 1, 2019
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
Miklos Rohla, Thomas W Weiss, Ladislav Pecen, et al.
Archives of Cardiovascular Diseases
|
September 25, 2017
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy
Raffaele De Caterina, Bernd Brüggenjürgen, Harald Darius, et al.
Circulation Reports
|
March 11, 2024
Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia - One-Year Data From the Global ETNA-AF Program
Jong-Il Choi, Songsak Kiatchoosakun, Panyapat Jiampo, et al.
Anticancer Research
|
October 4, 2011
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study
Petr Pazdiora, Sarka Svobodova, Radka Fuchsova, et al.
JACC. Advances
|
June 28, 2024
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry
Marianne Gwechenberger, Gonzalo Barón-Esquivias, Tim A C de Vries, et al.
International Journal of Cardiology
|
May 1, 2018
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy
Jolanta M Siller-Matula, Ladislav Pecen, Giuseppe Patti, et al.
Journal for Immunotherapy of Cancer
|
December 12, 2018
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
Iva Truxova, Lenka Kasikova, Michal Hensler, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
July 26, 2022
Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care
Paulus Kirchhof, Ladislav Pecen, Ameet Bakhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2019
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova, Jana Rakova, Michal Hensler, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
Michal Hensler, Lenka Kasikova, Karel Fiser, et al.
Page
of 9